A history of deep brain stimulation: Technological innovation and the role of clinical assessment tools
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Deep brain stimulation involves using a pacemaker-like device to deliver constant electrical stimulation to problematic areas within the brain. It has been used to treat over 40,000 people with Parkinson’s disease and essential tremor worldwide and is currently undergoing clinical trials as a treatment for depression and obsessive–compulsive disorder. This article will provide an historical account of deep brain stimulation in order to illustrate the plurality of interests involved in the development and stabilization of deep brain stimulation technology. Using Latour’s notion of immutable mobiles, this article will illustrate the importance of clinical assessment tools in shaping technological development in the era of medical device regulation. Given that such tools can serve commercial and professional interests, this article suggests that it is necessary to scrutinise their application in research contexts to ensure that they capture clinical changes that are meaningful for patients and their families. This is particularly important in relation to potentially ethically problematic therapies such as deep brain stimulation for psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“with about 40,000 PD and ET patients undergoing DBS worldwide by 2013 [12].”
From Controlling a motorized orthosis to follow elbow volitional movement: tests with individuals with pathological tremor (2019) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · Choice Reviews Online · doi:10.5860/choice.31-4888 · Cited by 9,294
(1987) · Cited by 8,955
Laboratory Life: The Construction of Scientific Facts
Latour, B. (1986) · DigitalGeorgetown (Georgetown University Library) · Cited by 7,491
Latour, B. (1987) · Cited by 4,106
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 1×
“Current clinical trials of DBS as a treatment for depression are using the Hamilton Rating Scale for Depression (HRSD) to generate the necessary evidence (Mayberg et al., 2005; Schlaepfer et al., 2008).”
MethodPrimate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824 · cited 1×
“One such avenue of research produced a model of a pathological chain of neural activity, in which the STN and the globus pallidus (GPi) are overactive (DeLong, 1990).”
BackgroundCore outcome measures for chronic pain clinical trials: IMMPACT recommendations
Dworkin, R. H., Turk, D. C., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Katz, N. P., Kerns, R. D., Stucki, G., Allen, R. R., Bellamy, N., et al. (2005) · Pain · doi:10.1016/j.pain.2004.09.012 · Cited by 3,732 · cited 2×
“(Dworkin et al., 2005).”
BackgroundCore outcome domains for chronic pain clinical trials: IMMPACT recommendations
Turk, D. C., Dworkin, R. H., Allen, R. R., Bellamy, N., Brandenburg, N., Carr, D. B., Cleeland, C., Dionne, R., Farrar, J. T., Galer, B. S., et al. (2003) · Pain · doi:10.1016/j.pain.2003.08.001 · Cited by 3,510
Gummett, P. (1988) · Physics Bulletin · doi:10.1088/0031-9112/39/8/019 · Cited by 2,974
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347
Recent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Mol, A. (2008) · doi:10.4324/9780203927076 · Cited by 2,002
Recent Developments in Parkinson's Disease
Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,920
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907 · cited 2×
“By surgically ablating these areas, researchers at Johns Hopkins University noted that they could reduce the induced-PD symptoms in primates (Bergman et al., 1990).”
BackgroundThe Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2003) · Movement Disorders · doi:10.1002/mds.10473 · Cited by 1,810 · cited 15×
“The UPDRS (like outcome measures in general) enabled the purification and inscription required to ‘construct’ factual statements regarding the efficacy of DBS.”
BackgroundInfluentialThe logic of care: health and the problem of patient choice
(2009) · Choice Reviews Online · doi:10.5860/choice.46-4482 · Cited by 1,623
Benabid, A. L., Pollak, P., Louveau, A., Henry, S., & de Rougemont, J. (1987) · Stereotactic and Functional Neurosurgery · doi:10.1159/000100803 · Cited by 1,378 · cited 1×
“From 1987 onwards, Benabid used Medtronic equipment to conduct trials of DBS of the areas within the thalamus to treat tremor in patients with either PD or essential tremor, some of whom showed complete relief (Benabid et al., 1987).”
MethodElectrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report.
Shealy, C. N., Mortimer, J. T., & RESWICK, J. B. (1990) · PubMed · Cited by 1,237
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148 · cited 1×
“Yet, from within psychiatry, the HRSD has been labelled as sufficiently ‘psychometrically and conceptually flawed’ that it warrants replacement (Bagby et al., 2004).”
BackgroundValidity and reliability of a rating scale for the primary torsion dystonias
Burke, R. E., Fahn, S., Marsden, C. D., Bressman, S. B., Moskowitz, C., & Friedman, J. (1985) · Neurology · doi:10.1212/wnl.35.1.73 · Cited by 1,118 · cited 1×
“The Burke–Fahn–Marsden Dystonia Rating Scale (BFMDRS), like the UPDRS, uses a series of numbers to indicate the severity of symptoms (Burke et al., 1985).”
MethodThe Zimbabwe Bush Pump: Mechanics of a Fluid Technology
de Laet, M., & Mol, A. (2000) · Social Studies of Science · doi:10.1177/030631200030002002 · Cited by 1,105
Lipcsey, A. (1980) · PubMed · Cited by 1,083
Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease
Laitinen, L. V., Bergenheim, A. T., & Hariz, M. I. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.1.0053 · Cited by 1,081 · cited 1×
“Alternative therapies were needed, and neurosurgeons were beginning to revisit pre-levodopa-era stereotactic surgical procedures (Bergman et al., 1990; Laitinen et al., 1992).”
BackgroundDeep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027 · cited 1×
“Current clinical trials of DBS as a treatment for depression are using the Hamilton Rating Scale for Depression (HRSD) to generate the necessary evidence (Mayberg et al., 2005; Schlaepfer et al., 2008).”
MethodElectrical Inhibition of Pain by Stimulation of the Dorsal Columns: Preliminary Clinical Report
SHEALY, C. N., MORTIMER, J. T., & RESWICK, J. B. (1967) · Anesthesia & Analgesia · doi:10.1213/00000539-196707000-00025 · Cited by 1,016 · cited 1×
“Electrodes were implanted within the spinal cords of a group of patients and connected to implanted Medtronic pacemakers modified to produce the higher frequency of stimulation required to modulate the perception of pain (Shealy et al., 1967: 490).”
MethodStereotaxic Apparatus for Operations on the Human Brain
Spiegel, E. A., Wycis, H. T., Marks, M., & Lee, A. J. (1947) · Science · doi:10.1126/science.106.2754.349 · Cited by 982 · cited 1×
“Surgeons can then plan their procedure to carefully avoid vital areas and navigate their way to areas deep within the brain (Spiegel et al., 1947).”
BackgroundWilliam Langston, J., Forno, L. S., Rebert, C. S., & Irwin, I. (1984) · Brain Research · doi:10.1016/0006-8993(84)90777-7 · Cited by 922 · cited 1×
“Subsequently, MPTP was used to create the first non-human primate models of PD (Chiueh et al., 1984; Langston et al., 1984), enabling new avenues of research into the underlying pathology, research that would have been unethical on afflicted human subjects.”
MethodThe Gold Standard-The Challenge of Evidence-Based Medicine and Standardization in Health Care
Stqan Timinerrnans and Marc Berg Tenrple University Press (2004) · Journal For Healthcare Quality · doi:10.1097/01445442-200407000-00016 · Cited by 783
The gold standard : the challenge of evidence-based medicine and standardization in health care
Timmermans, S., & Berg, M. (2003) · Cited by 758
Ritzer, G. (1996) · Medical Entomology and Zoology · Cited by 673
(2009) · Choice Reviews Online · doi:10.5860/choice.46-6522 · Cited by 523
Chronic Thalamic Stimulation for the Control of Facial Anesthesia Dolorosa
Hosobuchi, Y., Adams, J. E., & Rutkin, B. (1973) · Archives of Neurology · doi:10.1001/archneur.1973.00490270040005 · Cited by 384 · cited 2×
“patients who failed to respond satisfactorily to ablative therapy: electrodes were stereotactically implanted within the thalamus and connected to a pacemaker (Hosobuchi et al., 1973).”
BackgroundMechanisms of action of deep brain stimulation (DBS)
Montgomery, E. B., & Gale, J. T. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.06.003 · Cited by 344 · cited 4×
“In 1987, a consortium of movement specialists established the Movement Disorder Society and produced the Unified Parkinson’s Disease Rating Scale (UPDRS).”
BackgroundInfluentialMODULATION OF EMOTION WITH A BRAIN PACEMAKER TREATMENT FOR INTRACTABLE PSYCHIATRIC ILLNESS
HEALTH, R. G. (1977) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197711000-00002 · Cited by 322 · cited 1×
“At Tulane University, Robert Heath adopted Medtronic neurostimulators into his treatments for psychiatric disorders, particularly schizophrenia, reporting that some of these patients subsequently became symptom free (Heath, 1977; Heath et al., 1980).”
MethodDeep brain stimulation between 1947 and 1987: the untold story
Hariz, M. I., Blomstedt, P., & Zrinzo, L. (2010) · Neurosurgical Focus · doi:10.3171/2010.4.focus10106 · Cited by 232 · cited 1×
“As Hariz et al. (2010) point out, the common narrative of these overviews is that DBS was first developed in 1987 by a team treating patients with essential tremor and PD at Grenoble, France.”
BackgroundSUPPRESSION OF INTENTION TREMOR BY CONTINGENT DEEP-BRAIN STIMULATION
Brice, J., & Mclellan, L. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91680-3 · Cited by 198 · cited 1×
“They reported that some of their patients improved significantly: one patient who was initially totally disabled was subsequently able to ‘feed herself, light her own cigarettes, fasten her own buttons, and control bed light and radio’ (Brice and McLellan, 1980).”
BackgroundCooper, I. S., Upton, A. R. M., & Amin, I. (1980) · Stereotactic and Functional Neurosurgery · doi:10.1159/000102263 · Cited by 197 · cited 1×
“The well-known US neurosurgeon Irving Cooper, for instance, used the newly developed neurostimulators to stimulate the cerebellum and deep brain as treatments for cerebral palsy, epilepsy or dystonia in around 200 patients (Cooper et al., 1980; Cooper and Upton, 1978).”
MethodHunter, D. J. (2003) · Durham Research Online (Durham University) · Cited by 196
Espeland, W. (2010) · Contemporary Sociology: A Journal of Reviews · doi:10.1177/0094306110380384bb · Cited by 192
Deep Brain Stimulation for Chronic Pain: Results of Two Multicenter Trials and a Structured Review
Coffey, R. J. (2001) · Pain Medicine · doi:10.1046/j.1526-4637.2001.01029.x · Cited by 189 · cited 2×
“Engineers at Medtronic had conducted studies to assess the use of their stimulation technology to manage pain, but these were abandoned due to the lack of any definitive results (the findings were eventually published in Coffey, 2001).”
BackgroundThe artificial ear: cochlear implants and the culture of deafness
(2010) · Choice Reviews Online · doi:10.5860/choice.47-6896 · Cited by 186
Ethical issues in deep brain stimulation
Schermer, M. (2011) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2011.00017 · Cited by 183 · cited 2×
“…and invasive nature of DBS, the difficulty of managing patients’ expectations and the unknown extent of psychosocial adverse effects necessitate the formation of clear ethical guidelines (Bell et al., 2009; Schermer, 2011) and the careful monitoring of clinical outcomes (Schlaepfer and Fins, 2010).”
BackgroundModeling Parkinson's Disease in Primates: The MPTP Model
Porras, G., Li, Q., & Bezard, E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009308 · Cited by 181 · cited 1×
“The substance was identified as 1-methyl4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and an autopsy later revealed that it had destroyed the dopamine producing cells of the substantia nigra, the same area that degenerates in PD (Porras et al., 2012).”
BackgroundPorter, T. M. (1994) · Science in Context · doi:10.1017/s0269889700001757 · Cited by 181 · cited 1×
“Third, as Porter (1994) has made quite clear, by eliding personal detail, such renderings are imbued with an authority resulting from their supposed objectivity.”
BackgroundDeep Brain Stimulation Devices: A Brief Technical History and Review
Coffey, R. J. (2009) · Artificial Organs · doi:10.1111/j.1525-1594.2008.00620.x · Cited by 178 · cited 1×
“Medtronic officially established a neurological division in 1975, and it was while marketing its device for the treatment of pain that Medtronic trademarked the term ‘DBS’ (Coffey, 2009).”
BackgroundJermier, J. M. (1995) · The Leadership Quarterly · doi:10.1016/1048-9843(95)90007-1 · Cited by 177
Psychosurgery: past, present, and future
Mashour, G. A., Walker, E. E., & Martuza, R. L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.09.002 · Cited by 174 · cited 2×
“…medications in the mid-1950s, this and the much more crude frontal lobotomy were heralded as much-needed treatments for patients with psychiatric disorders, disorders that were considered to be a huge financial burden on society, particularly in the United States (Mashour et al., 2005).”
BackgroundChiueh, C. C., Markey, S. P., Burns, R. S., Johannessen, J. N., Jacobowitz, D. M., & Kopin, I. J. (1984) · PubMed · Cited by 169
Teaching tape for the motor section of the unified Parkinson's disease rating scale
Goetz, C. G., Stebbins, G. T., Chmura, T. A., Fahn, S., Klawans, H. L., & Marsden, C. D. (1995) · Movement Disorders · doi:10.1002/mds.870100305 · Cited by 154
Preparing the ethical future of deep brain stimulation
Bell, E. C., Mathieu, G., & Racine, É. (2009) · Surgical Neurology · doi:10.1016/j.surneu.2009.03.029 · Cited by 147 · cited 2×
“…and invasive nature of DBS, the difficulty of managing patients’ expectations and the unknown extent of psychosocial adverse effects necessitate the formation of clear ethical guidelines (Bell et al., 2009; Schermer, 2011) and the careful monitoring of clinical outcomes (Schlaepfer and Fins, 2010).”
BackgroundEffects of Stimulating or Destroying the Deep Cerebellar Regions in Man
Nashold, B. S., & Slaughter, D. G. (1969) · Journal of Neurosurgery · doi:10.3171/jns.1969.31.2.0172 · Cited by 146 · cited 3×
“(Nashold and Slaughter, 1969: 243) Noting the therapeutic effect of higher frequency stimulation, some surgeons carried out chronic stimulation on their patients.”
BackgroundMethodInfluentialDeep Brain Stimulation and the Neuroethics of Responsible Publishing
Schlaepfer, T. E., & Fins, J. J. (2010) · JAMA · doi:10.1001/jama.2010.140 · Cited by 142 · cited 1×
“…and invasive nature of DBS, the difficulty of managing patients’ expectations and the unknown extent of psychosocial adverse effects necessitate the formation of clear ethical guidelines (Bell et al., 2009; Schermer, 2011) and the careful monitoring of clinical outcomes (Schlaepfer and Fins, 2010).”
BackgroundNew medical technologies and society: reordering life
(2005) · Choice Reviews Online · doi:10.5860/choice.42-4711 · Cited by 127
Mundinger, F. (1977) · PubMed · Cited by 126
How medical practice evolves: Learning to treat failing hearts with an implantable device
Morlacchi, P., & Nelson, R. R. (2011) · Research Policy · doi:10.1016/j.respol.2011.01.001 · Cited by 123 · cited 5×
“Science and Technology Studies and the dynamics of technological development As Morlacchi and Nelson (2011) point out, linear narratives of scientific discovery and medical progress are common to accounts of medical device development.”
BackgroundInfluential(1988) · Elsevier eBooks · doi:10.1016/c2013-0-06464-x · Cited by 119
Gildenberg, P. L. (2005) · Stereotactic and Functional Neurosurgery · doi:10.1159/000086865 · Cited by 118 · cited 3×
“In a recent retrospective, Philip Gildenberg, a stereotactic neurosurgeon at the time, gives us some idea as to why neurosurgeons were receptive to neurostimulation technology.”
BackgroundFins, J. J., Mayberg, H. S., Nuttin, B., Kubu, C. S., Galert, T., Sturm, V., Stoppenbrink, K., Merkel, R., & Schlaepfer, T. E. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.0157 · Cited by 117 · cited 2×
“regulatory exemption in order to facilitate the dissemination of their DBS technology (Fins et al., 2011).”
BackgroundMundinger, F. (2009) · Confinia Neurologica · doi:10.1159/000104030 · Cited by 110 · cited 1×
“In patients with motor disorders, it was noted that lower frequency stimulation of particular areas could exacerbate symptoms, while higher frequencies could reduce symptoms (French et al., 1962; Mundinger, 1965).”
BackgroundThe cerebellar pacemaker for intractable behavioral disorders and epilepsy: follow-up report.
Heath, R. G., Llewellyn, R. C., & Rouchell, A. M. (1980) · PubMed · Cited by 109
“Currents of Hope”: Neurostimulation Techniques in U.S. and U.K. Print Media
Racine, É., Waldman, S., Palmour, N., Risse, D., & Illes, J. (2007) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180107070351 · Cited by 104 · cited 1×
“Stories of previously housebound patients with debilitating symptoms subsequently regaining independence and self-confidence with DBS are not uncommon, and the media has tended to portray the therapy in very optimistic terms (Gilbert and Ovadia, 2011; Racine et al., 2007).”
BackgroundThalamic Stimulation for Control of Movement Disorders
Andy, O. J. (1983) · Stereotactic and Functional Neurosurgery · doi:10.1159/000101248 · Cited by 104 · cited 1×
“His views were echoed by Orlando Andy (1983) of Mississippi, who was using stimulation of areas within the thalamus to treat nine patients with PD who had failed to respond to levodopa therapy.”
BackgroundDeep brain stimulation for movement disorders before DBS for movement disorders
Blomstedt, P. C., & Hariz, M. I. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.04.005 · Cited by 97 · cited 1×
“Andy reported that the results of stimulating the thalamus at high frequencies in nine patients with motor disorders were ‘fair to excellent’ (Blomstedt and Hariz, 2010: 431), and Heath et al. (1980), reporting on a study of 38 patients, argued that those with depression, ‘behavioral pathology…”
BackgroundPENFIELD, W. (1936) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1936.02260090002001 · Cited by 96 · cited 1×
“By noting the patient’s response when stimulating various regions, the surgeon hoped to locate, and subsequently destroy, the particular area implicated in the patient’s seizures (Penfield, 1936).”
BackgroundIrving S. Cooper and His Role in Intracranial Stimulation for Movement Disorders and Epilepsy
Rosenow, J., Das, K., Rovit, R. L., & Couldwell, W. T. (2002) · Stereotactic and Functional Neurosurgery · doi:10.1159/000068011 · Cited by 95 · cited 2×
“Despite Cooper’s belief that they ‘yielded promising clinical results’, the lack of uniform objective evaluations to quantify and measure clinical improvement meant that the ‘true benefit’ could not ‘be elucidated’ (Rosenow et al., 2002).”
BackgroundElectrical Stimulation and the Relief of Pain
Krames, E. S. (2004) · Neuromodulation Technology at the Neural Interface · doi:10.1111/j.1094-7159.2004.04203.x · Cited by 94 · cited 1×
“Medtronic was the first to do so in 1968, followed by Avery Laboratories in 1972 and then Cordis, the second largest producer of pacemakers behind Medtronic (Rossi, 2003: 10).”
BackgroundGilbert, F., & Ovadia, D. (2011) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2011.00016 · Cited by 79
Coffey, R. J., & Lozano, A. M. (2006) · Journal of neurosurgery · doi:10.3171/jns.2006.105.2.175 · Cited by 72 · cited 2×
“With regard to neurostimulation technology used in DBS and cerebral stimulation therapies, the FDA decided that clinical trials would be necessary before it could be marketed (Coffey and Lozano, 2006).”
BackgroundThe Artificial Ear: Cochlear Implants and the Culture of Deafness
Blume, S. S. (2019) · Rutgers University Press eBooks · doi:10.36019/9780813549118 · Cited by 70
Becoming Borg to Become Immortal: Regulating Brain Implant Technologies
McGee, E. M., & Maguire, G. Q. (2007) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180107070326 · Cited by 67 · cited 1×
“Such accounts render DBS a small but definite movement towards neurotechnologies with a potential to significantly affect that which we think of as ‘human’ (McGee and Maguire, 2007).”
BackgroundMedical Technology into Healthcare and Society
Faulkner, A. (2009) · Palgrave Macmillan UK eBooks · doi:10.1057/9780230228368 · Cited by 65 · cited 1×
“As Faulkner states, this plurality of interests, both public and private, is characteristic of medical innovation within neo-liberal economies (Faulkner, 2009: 7).”
BackgroundUSE OF CHRONIC CEREBELLAR STIMULATION FOR DISORDERS OF DISINHIBITION
Cooper, I. S., & Upton, A. R. M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91038-3 · Cited by 64 · cited 2×
“The well-known US neurosurgeon Irving Cooper, for instance, used the newly developed neurostimulators to stimulate the cerebellum and deep brain as treatments for cerebral palsy, epilepsy or dystonia in around 200 patients (Cooper et al., 1980; Cooper and Upton, 1978).”
BackgroundMethodConflicts of Interest in Deep Brain Stimulation Research and the Ethics of Transparency
Fins, J. J., & Schiff, N. D. (2010) · The Journal of Clinical Ethics · doi:10.1086/jce201021205 · Cited by 60 · cited 2×
“clinical assessment tools, deep brain stimulation, immutable mobiles, industry, innovation, medical device, technology”
BackgroundNew Medical Technologies and Society - Reordering Life
Prainsack, B. (2004) · Science & Technology Studies · doi:10.23987/sts.55167 · Cited by 58 · cited 1×
“No technology ‘ever speaks for itself’ (Brown and Webster, 2004: 38).”
BackgroundMedical Technology into Healthcare and Society: A Sociology of Devices, Innovation and Governance
Faulkner, A. (2008) · Cited by 57
Chen, X. L., Xiong, Y. Y., Xu, G. L., & Liu, X. F. (2012) · Interventional Neurology · doi:10.1159/000353121 · Cited by 52
Totally Implantable Spinal Cord Stimulation for Chronic Pain: Design and Efficacy
Shatin, D., Mullett, K., & HULTS, G. (1986) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1986.tb06614.x · Cited by 50 · cited 5×
“Again, these incremental developments were the result of technology transfer from the ongoing financially lucrative improvements associated with the pacemaker (Shatin et al., 1986).”
BackgroundResultInfluentialObesity and Brain Addiction Circuitry: Implications for Deep Brain Stimulation
Taghva, A., Corrigan, J. D., & Rezai, A. R. (2012) · Neurosurgery · doi:10.1227/neu.0b013e31825972ab · Cited by 43 · cited 1×
“More recently, investigators have begun exploring DBS as a possible treatment for severe obesity (Taghva et al., 2012).”
BackgroundSem-Jacobsen, C. W. (1966) · PubMed · Cited by 42
Deep Brain Stimulation: Avoiding the Errors of Psychosurgery
Kringelbach, M. L., & Aziz, T. Z. (2009) · JAMA · doi:10.1001/jama.2009.551 · Cited by 40 · cited 1×
“Such comparisons refer to the capacity of neurosurgical therapies to threaten identity and the sense of self and suggest that the spectre of psychosurgery is a necessary reminder of the need for caution (Gillett, 2011; Kringelbach and Aziz, 2009).”
BackgroundGildenberg, P. L. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374248-3.00003-3 · Cited by 27 · cited 4×
“Neurostimulation provided an opportunity, for some neurosurgeons at least, to utilise their skills and equipment and provide potentially effective surgical treatments for other conditions or for those few patients with PD who could not tolerate levodopa (Gildenberg, 2009: 14).”
BackgroundInfluentialState of the Art in Neurostimulation
Mullett, K. (1987) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1987.tb05945.x · Cited by 21 · cited 2×
“Newspaper articles, press releases, transcripts of FDA panel hearings and meetings (available online), secondary historical documents and accounts produced by engineers (Mullett, 1987; Shatin et al., 1986), Medtronic medical advisors (Coffey, 2001, 2008) and numerous clinicians, particularly the neurosurgeons Philip G…”
BackgroundSESSION II: Deep Brain Stimulation
Siegfried, J., & SHULMAN, J. (1987) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1987.tb05961.x · Cited by 18 · cited 1×
“Problems with components were not unusual and these were subject to incremental modifications: the electrodes used in DBS could fray and turn on their axis (Siegfried and Shulman, 1987); complications arose from lead implantation and the power source could fail (Shatin et al., 1986).”
BackgroundHealth programs struggling with complexity: A case study of the Dutch ‘PreCare’ project
Wehrens, R., & Bal, R. A. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.02.052 · Cited by 17 · cited 1×
“The diffusion of such tools is part of what several authors have referred to as ‘rationalisation healthcare’, linked to the EBM movement (Hunter, 2003; Porter, 1995; Wehrens and Bal, 2012).”
BackgroundSome Aspects of Stimulation and Recording from the Basal Ganglia in Patients with Abnormal Movements
French, L. A., Story, J. L., Galicich, J. H., & Schultz, E. A. (2007) · Confinia Neurologica · doi:10.1159/000104370 · Cited by 17 · cited 1×
“In patients with motor disorders, it was noted that lower frequency stimulation of particular areas could exacerbate symptoms, while higher frequencies could reduce symptoms (French et al., 1962; Mundinger, 1965).”
BackgroundDeep Brain Stimulation: A New Life for People with Parkinson's, Dystonia, and Essential Tremor
Chou, K. L. (2011) · Cited by 17
Foote, S. B. (1978) · Ecology law quarterly · doi:10.15779/z388r6m · Cited by 16 · cited 3×
“The intention of the amendments was to provide a ‘reasonable assurance of safety and effectiveness for all devices’ (Foote, 1978).”
BackgroundRhoton, A. L. (2011) · World Neurosurgery · doi:10.1016/j.wneu.2011.01.025 · Cited by 14
Hard science, hard choices: facts, ethics, and policies guiding brain science today
Chapman, A. H. (2006) · Choice Reviews Online · doi:10.5860/choice.44-2097 · Cited by 9
Hj, G. (1961) · PubMed · Cited by 8
Upton, A. R. M., & Lazorthes, Y. R. (1987) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1987.tb05944.x · Cited by 4
&NA; (1958) · Southern Medical Journal · doi:10.1097/00007611-195812000-00039 · Cited by 4
Upton, A. R. M. (1986) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1986.tb05354.x · Cited by 4
The Gold-Plated Leucotomy Standard and Deep Brain Stimulation
Gillett, G. R. (2011) · Journal of Bioethical Inquiry · doi:10.1007/s11673-010-9281-z · Cited by 3 · cited 1×
“Such comparisons refer to the capacity of neurosurgical therapies to threaten identity and the sense of self and suggest that the spectre of psychosurgery is a necessary reminder of the need for caution (Gillett, 2011; Kringelbach and Aziz, 2009).”
BackgroundHester, M. D. (2007) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180107070284 · Cited by 3
Research works printed but not linked: 6
- 10. Breggin P. (1972) The return of lobotomy and psychosurgery. Congressional Record, 24 February Washington, DC: United States Government Printing Office
- 54. Medtronic (2010) Innovating for Life: 2010 Annual Report. Minneapolis, MN: Medtronic
- 60. Mundinger F. (1977) New stereotactic treatment of spasmodic torticollis with a brain stimulation system. Medizinische Klinik 72: 1982–1986
- 65. Porter TM. (1995) Trust in Numbers: The Pursuit of Objectivity in Science and Daily Life. Princeton, NJ: Princeton University Press
- 66. Rabinow P. (ed.) (1991) The Foucault Reader: An Introduction to Foucault’s Thought. London: Penguin
- 81. Talan J. (2009) Deep Brain Stimulation: A New Treatment Shows Promise in the Most Difficult Cases. New York: Dana Press
Cited by
Emerging Modalities and Implantable Technologies for Neuromodulation
Won, S. M., Song, E., Reeder, J. T., & Rogers, J. A. (2020) · Cell · doi:10.1016/j.cell.2020.02.054 · Cited by 291
“The adaptation of cardiac pacemaker technology into platforms to treat chronic pain in the late 1960s (Gardner, 2013) led to the development of techniques for electrical neuromodulation in the context of many other conditions, including deepbrain stimulation (DBS) for Parkinson’s disease, spinal…”
BackgroundGladden, M. E. (2019) · Social Sciences · doi:10.3390/socsci8050148 · Cited by 270
“…by the Japanese robotics company FANUC (Metzger 2016); the creation of the first commercial deep brain stimulation (DBS) implants, around 2002 (Gardner 2013); the first use of therapeutic social robots (e.g., PARO), around 2004 (Shibata et al. 2004); the introduction of robot chefs that…”
BackgroundTowards network-guided neuromodulation for epilepsy
Piper, R. J., Richardson, R. M., Worrell, G., Carmichael, D. W., Baldeweg, T., Litt, B., Denison, T., & Tisdall, M. M. (2022) · Brain · doi:10.1093/brain/awac234 · Cited by 242
Powering implantable and ingestible electronics
Yang, S., Sencadas, V., You, S. S., Jia, N. Z., Srinivasan, S. S., Huang, H., Ahmed, A. E., Liang, J. Y., & Traverso, G. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009289 · Cited by 183
Closing the Loop on Deep Brain Stimulation for Treatment-Resistant Depression
Widge, A. S., Malone, D. A., & Dougherty, D. D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00175 · Cited by 143
“DBS developed when functional neurosurgeons noted that highfrequency electrical stimulation mimicked the effect of lesioning the same brain area (Gardner, 2013; Miocinovic et al., 2013).”
BackgroundMethodInfluential
Metadata
- Authors
- Gardner, J.
- Affiliations
- Brunel University of London (GB)
- Corresponding author
- Gardner, John
- ORCID
- Gardner, John
- Venue
- Social Studies of Science
- Publisher
- SAGE Publications
- Published
- 2013-05-30
- Volume
- 43
- Issue
- 5
- Pages
- 707-728
- ISSN
- 0036-8539 (ISSN-L)
- 0306-3127
- 1460-3659
- PMC
- PMC3785222
- OpenAlex
- W2106186877
- Cited by
- 243
- References
- 94
- Citations by year
- 2026: 27 · 2025: 16 · 2024: 29 · 2023: 24 · 2022: 29 · 2021: 22 · 2020: 26 · 2019: 30 · 2018: 15 · 2017: 8 · 2016: 7 · 2015: 7 · 2014: 3
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Social Studies of Science (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- Funders
- Wellcome Trust (086034)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Life Sciences › Neuroscience › Neurology › Neurology and Historical Studies
- Keywords
- deep brain stimulation, history of technology, clinical assessment tools, Parkinson's disease, essential tremor, depression, obsessive-compulsive disorder, medical device regulation, technological progress, patient and family perspectives
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.